￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Discussion on the monthly treatment cost of lorlatinib/lorlatinib

2026-02-01 22:25:32

Check Details
Clinical study of lorlatinib/lorlatinib in the treatment of ROS1-positive non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Lorlatinib/Lorlatinib: New Trends in Market Prices

2026-02-01 22:25:32

Check Details
What are the adverse reactions of lorlatinib/lorlatinib?

2026-02-01 22:25:32

Check Details
Is there a fourth generation of resistance to lorlatinib/lorlatinib?

2026-02-01 22:25:32

Check Details
Can lorlatinib/lorlatinib cure lung cancer?

2026-02-01 22:25:32

Check Details
Lorlatinib/lorlatinib API 3922

2026-02-01 22:25:32

Check Details
How many days does it take to see the effect of lorlatinib/lorlatinib?

2026-02-01 22:25:32

Check Details
The difference between lorlatinib/lorlatinib and alectinib

2026-02-01 22:25:32

Check Details
Better fourth-generation drugs than lorlatinib/lorlatinib

2026-02-01 22:25:32

Check Details
Effects and limitations of lorlatinib/lorlatinib in the treatment of lung cancer

2026-02-01 22:25:32

Check Details
The relationship between lorlatinib/lorlatinib and API 3922

2026-02-01 22:25:32

Check Details
Category
相关知识